v3.25.4
Stock-based Compensation (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
Offering_Period
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award      
Number of shares reserved for issuance to recipient (in shares) 284,000    
Number of shares available for future grant (in shares) 16,000    
Granted 0    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Proceeds from issuance of common stock | $ $ 98,000 $ 105,000 $ 136,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility 35.00% 30.00% 48.00%
Expected dividend yield 2.78% 2.00% 1.44%
Risk-free interest rate 4.28% 5.24% 5.11%
Weighted average grant-date fair value per share | $ / shares $ 4.17 $ 5.60 $ 7.16
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award      
Vesting period 3 years    
Expiration from date of award (in years) 10 years    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding at beginning of period 10,400    
Exercised 0    
Forfeited/expired (2,400)    
Outstanding at end of period 8,000 10,400  
Number of shares exercisable at the end of the period 8,000    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Outstanding- weighted average exercise price at beginning of period (in dollars per share) | $ / shares $ 41.75    
Exercised | $ / shares 24.73    
Forfeited/expired | $ / shares 43.71    
Outstanding- weighted average price per share end of period (in dollars per share) | $ / shares $ 41.23 $ 41.75  
Weighted Average Remaining Contractual Term (years) 1 year 10 months 24 days    
Aggregate intrinsic value | $ $ 5,800    
Weighted Average Exercise Price per Share, Exercisable at the end of the period | $ / shares   $ 41.23  
Weighted Average Remaining Contractual Term (years), Exercisable at the end of the period 1 year 10 months 24 days    
Aggregate Intrinsic Value, Exercisable at the end of the Period | $ $ 5,800    
Intrinsic value of stock options exercised during the period | $ 103 $ 3,000 $ 20,000
Unrecognized compensation cost, non vested awards at period end | $ 0    
Proceeds from issuance of common stock | $ 98,000 105,000 136,000
Exercise of stock options      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Proceeds from issuance of common stock | $ 1,000 9,000 48,000
Stock incentive plans      
Share-based Compensation Arrangement by Share-based Payment Award      
Stock-based compensation cost | $ 213,000 223,000 219,000
Tax benefit | $ (36,000) (38,000) (36,000)
Stock-based compensation cost, net of tax | $ $ 177,000 $ 185,000 $ 183,000
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award      
Expiration from date of award (in years) 5 years    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]      
Unrecognized compensation cost, non vested awards at period end | $ $ 358,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Nonvested shares at beginning of the period 19,500    
Granted 7,800    
Vested (6,900)    
Forfeited (1,700)    
Nonvested shares at end of the period 18,700 19,500  
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Weighted Average Grant-Date Fair Value per Share, Nonvested shares at the beginning of the period | $ / shares $ 31.64    
Granted | $ / shares 22.95 $ 36.76 $ 31.73
Vested | $ / shares 29.18    
Forfeited | $ / shares 30.84    
Weighted Average Grant-Date Fair Value per Share, Nonvested shares at the end of the period | $ / shares $ 29.01 $ 31.64  
Total fair value of shares vested during the period | $ $ 162,000 $ 263,000 $ 283,000
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award      
Number of shares reserved for issuance to recipient (in shares) 104,000    
Employee stock purchase plan [Abstract]      
Percentage of earnings eligible employees may have withheld under the employee stock purchase plan 10.00%    
Number of offering periods | Offering_Period 4    
Percentage of the lower of fair market value of the unit on the commencement date or the fair market value of unit on the last trading day of the offering period 90.00%    
Number of shares sold through the plan (in shares) 84,000    
Shares available for future issuance through the plan 20,000